HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 30 filers reported holding HISTOGENICS CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $98,000 | – | 39,175 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| S Squared Technology, LLC | 1,169,387 | $2,923,000 | 2.32% |
| Abingworth LLP | 888,889 | $2,204,000 | 1.26% |
| Sofinnova Investments, Inc. | 4,154,080 | $10,386,000 | 0.66% |
| Third Security, LLC | 2,690,570 | $6,726,000 | 0.54% |
| Archon Capital Management LLC | 293,090 | $733,000 | 0.23% |
| Perceptive Advisors | 2,203,277 | $5,508,000 | 0.14% |
| Endurant Capital Management LP | 56,177 | $140,000 | 0.06% |
| Sio Capital Management, LLC | 39,175 | $98,000 | 0.05% |
| Palo Alto Investors LP | 302,922 | $757,000 | 0.03% |
| Rossmore Private Capital | 11,236 | $28,000 | 0.02% |